| Non-specific Immunotherapy with Histamine-Gammalobulin Preparations in Chronic Respiratory Group Patients and Non-atopic Asthmatic Children. |
|
Byeung Ju Jeoung, Kyu Earn Kim, Ki Young Lee |
|
Department of Pediatrics, Yonsei University, College of Medicine, Seoul, Korea |
| 만성 호흡기질환군 및 비아토피성 천식환아에서
Histamine-Gammaglobulin 제제로 실시한
비특이적 면역요법 |
|
정병주, 김규언, 이기영 |
|
연세대학교 의과대학 소아과학교실 |
|
Received: 27 April 1988 • Accepted: 27 April 1988 |
|
|
| Abstract |
|
We evaluated the therapeutic effect of non-specific immunotherapy with Histamine-
gammahlobulin in 60 patients. Among them 22 patients were chronic respiratory group patients who
were under 2 years of age and suffered from frequent respiratory tract infections, and 38 patients were
as follows:
1) Excluding the patients who received 9 weeks therapy for the test period, the mean duration of
Histamine-gammaglobulin therapy in the chronic respiratory group patients(9.4 months) was shorter
than that of the non-atopic asthmatic children(21.1 months). We suggest that the latter disease
presents more involved and troublesome problems to the patients and their parents.
2) There was clinical improvement in 63.6% of the chronic respiratory group patients after
Histmine-gammaglobulin therapy; 18.2% of the patients exhibited excellent improvement and good
and fair results were each seen in 22.7% of the patients, respectively. The patients who exhibited good
to excellent improvement received Histamine-gammaglobulin therapy for approximately 1 year.
3) There was clinical improvement in 52.6% of the non-atopic asthma patients after Histamine-
gammaglobulin therapy; 21.1% of the patients showed excellent improvement, 18.4% good and 13.1%
fair. There was no significant correlation between the effecacy of Histamine-gammaglobulin therapy
and the severity of asthma.
4) We evaluated the efficacy of Histamine-hammaglobulin therapy on 14 non-atopic asthmatic
children who were treated for more than one year. At the short term follow-up, after 9 injections,
excellent results were seen in only 2 patients but at the long term follow-up, excellent results were
noted in 5 patients. Good and fair results at the short term follow-up were seen in 8 and 4 patients,
but at the long term follow-up, after about 27 months of therapy, this changed to 4 and 2 patients,
respectively.
There were 3 patients who presented good results at the short term follow-up, but at the long term
follow-up, after about 22 months of therapy, this changed to not effective.
Histamine-gammaglobulin therapy appered to be effective in both the chronic respiratory group
patients and the non-atopic asthmatic children, if the pateint was selected properly. The efficacy of
Histamine-gammaglobulin therapy is better determined after long term follow-up. |
| Key Words:
Histamine-gammaglobulin, Chronic respiratory group, Non-atopic asthma |
|
PDF Links
Download Citation
